entrepreneurship

University of Toronto: Snapshot of Toronto’s Entrepreneurship Scene

The University of Toronto’s news site has posted a brief snapshot of Toronto’s entrepreneurial scene, highlighting the university’s historical and current innovative strengths.

Here’s a brief excerpt:

Entrepreneurs don’t have to be in Silicon Valley to become the next great business success story. Toronto now ranks fourth among the world’s top 25 start-up ecosystems, according to Start-up Genome, a project that maps the success rates of start-ups. Toronto ranks just behind Silicon Valley, New York City and London.

OtoSim Inc. Makes a Sound Pitch on BNN

OtoSim listens to the Verdict on BNN's The Pitch — Louis Hui (far left) listens to the panel’s comments on BNN’s The Pitch.

OtoSim Inc., a MaRS Innovation spin-off company, made its debut on Business News Network’s The Pitchon June 1, 2012.

Louis Hui, OtoSim’s business development manager, had 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts.

OtoSim Inc. to Appear on BNN’s The Pitch

OtoSim Inc., a MaRS Innovation spin-off company, is taping an appearance on Business News Network’s The Pitch on May 22, 2012.

Louis Hui, OtoSim’s business development manager, will have 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts.

Video: Canadian International Council interviews Rafi Hofstein about commercializing Canadian technology

October 11, 2011
Susanne Staer
News

Dr. Raphael Hofstein, president and CEO of MaRS Innovation, spoke to the Canadian International Council about the importance of protecting intellectual property as an important component in commercializing Canadian technologies.

Here’s an excerpt:

Government could be extremely helpful if they created special funds dedicated to covering the costs of patent protection.

Vasculotide: sanofi-aventis, Sunnybrook and MI – Article in the Globe and Mail

February 15, 2011
Susanne Staer
Media Coverage

A discovery that could help millions of diabetics worldwide is the subject of a lucrative pharmaceutical deal that will enrich the Toronto hospital that created it – part of a growing trend of selling science to help shore up Canada’s troubled health-care system.

Tuesday’s agreement between Sanofi-Aventis and Sunnybrook Health Sciences Centre on a wound-healing molecule demonstrates how entrepreneurial hospitals can become when the very sustainability of medicare is in question.

But the licensing deal with one of the world’s biggest drug companies is also savvy medically. Until recently, some hospitals were reticent to capitalize on their discoveries, seeing commercialization as unsavoury, but now many believe it’s one of the quickest ways to get a drug to their patients.

University of Toronto: Snapshot of Toronto’s Entrepreneurship Scene

OtoSim Inc. Makes a Sound Pitch on BNN

OtoSim Inc. to Appear on BNN’s The Pitch

Video: Canadian International Council interviews Rafi Hofstein about commercializing Canadian technology

Vasculotide: sanofi-aventis, Sunnybrook and MI – Article in the Globe and Mail

Quick Links

Contact Us